Emerging targets in gastroesophageal adenocarcinoma: what the future looks like

Gastroesophageal adenocarcinoma (GEA) is a heterogeneous disease with a poor prognosis. Chemotherapy has been the cornerstone in treating metastatic diseases. Recently, the introduction of immunotherapy demonstrated improved survival outcomes in localized and metastatic diseases. Beyond immunotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrillo, Angelica, Smyth, Elizabeth C., van Laarhoven, Hanneke W. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184253/
https://www.ncbi.nlm.nih.gov/pubmed/37197225
http://dx.doi.org/10.1177/17588359231173177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184253/
https://www.ncbi.nlm.nih.gov/pubmed/37197225
http://dx.doi.org/10.1177/17588359231173177

Ejemplares similares